ESG Report

Overview

The report highlights DFE Pharma's 2024 EcoVadis Gold Medal, placing it in the top 5% of rated companies, and SBTi approval of its near-term and FLAG targets. It reports 446 employees and detailed 2024 ESG data, including 827,985 ton CO2 eq. of total GHG emissions and 278,657 GJ of total energy consumption. The report also emphasizes improved Scope 3 data quality following recalculation using more supplier-specific information.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services